Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - TG THERAPEUTICS, INC. | exhibit32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - TG THERAPEUTICS, INC. | exhibit31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC. | exhibit31-1.htm |
| 10-Q - 10-Q - TG THERAPEUTICS, INC. | TG10-Q12018.htm |
Exhibit 32.2
STATEMENT
OF CHIEF FINANCIAL OFFICER OF
TG
THERAPEUTICS, INC.
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the quarterly report of TG Therapeutics, Inc. (the
“Company”) on Form 10-Q for the period ended March 31,
2018 as filed with the Securities and Exchange Commission (the
“Report”), I, Sean A. Power, Chief Financial Officer of
the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that,
based on my knowledge:
1) The Report
fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
2) The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
|
Date: May 10,
2018
|
|
/s/ Sean A.
Power
|
|
|
Sean A.
Power
Chief
Financial Officer
Principal Financial
and Accounting Officer
|
|